Moreover, the high level of GSH in the tumor cytosol led to the rapid release of the loaded drugs, resulting in PD‐1‐/PD‐L1‐blockading‐mediated immunomodulation to enhance tumor immunotherapy. This evidence concerns the gene CD274 and neoplasm.